Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 329.39 | 8.79 | (35.40)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 384.83 | 49.07 | 45.87¢ | 24.4 | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 440.01 | 79.77 | 63.97¢ | 17.5 | 0.4 | +40% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
Dynavax, Merck team up on hepatitis B vaccine | 02-Nov-2007 | BayArea.com |
Merck Buys License to Sell New Vaccine for Hepat... | 01-Nov-2007 | New York Times |
Business Digest | 20-Jan-2006 | BayArea.com |
Currency | US Dollars |
Share Price | $ 11.06 |
Change Today | $ -0.13 |
% Change | -1.16 % |
52 Week High | $14.40 |
52 Week Low | $9.51 |
Volume | 1,617,927 |
Shares Issued | 65.06m |
Market Cap | $719.61m |
RiskGrade | 699 |
Strong Buy | 1 |
Buy | 3 |
Neutral | 0 |
Sell | 1 |
Strong Sell | 0 |
Total | 5 |
Time | Volume / Share Price |
16:00 | 211,160 @ $11.06 |
15:59 | 2,302 @ $11.06 |
15:59 | 500 @ $11.06 |
15:59 | 3,768 @ $11.07 |
15:59 | 126 @ $11.07 |
You are here: research